首页>Clinical Pharmacology and Therapeutics>FIRST-IN-HUMAN PHARMACOKINETIC, PHARMACODYNAMICS, AND SAFETY PROFILE OF A FAS ASSOCIATED FACTOR 1 INHIBITOR (K-M-819) IN HEALTHY VOLUNTEERS.
FIRST-IN-HUMAN PHARMACOKINETIC, PHARMACODYNAMICS, AND SAFETY PROFILE OF A FAS ASSOCIATED FACTOR 1 INHIBITOR (K-M-819) IN HEALTHY VOLUNTEERS.
作者单位：PAREXEL Int, Glendale, CA USA[1]Kainos Med Inc, Seongnam, South Korea[2]PAREXEL Int, Durham, NC USA[3]CHA Bundang Med Ctr, Dept Neurol, Seongnam, South Korea[4]CHA Bundang Med Ctr, Dept Clin Pharmacol & Therapeut, Seongnam, South Korea[5]
换一批
